Phase II Study of Neoadjuvant Androgen Deprivation Followed by External-Beam Radiotherapy With 9 Months of Androgen Deprivation for Intermediate- to High-Risk Localized Prostate Cancer

MLA

Kathleen O’Toole, et al. “Phase II Study of Neoadjuvant Androgen Deprivation Followed by External-Beam Radiotherapy With 9 Months of Androgen Deprivation for Intermediate- to High-Risk Localized Prostate Cancer.” Journal of Clinical Oncology, vol. 25, Jan. 2007, pp. 77–84. EBSCOhost, https://doi.org/10.1200/jco.2005.05.0419.

APA

Kathleen O’Toole, Bozena K. Malyszko, Mahesh M. Mansukhani, Rachel Brody, Jonas J. Heymann, Mitchell C. Benson, Darleen Vecchio, Ronald D. Ennis, & Peter B. Schiff. (2007). Phase II Study of Neoadjuvant Androgen Deprivation Followed by External-Beam Radiotherapy With 9 Months of Androgen Deprivation for Intermediate- to High-Risk Localized Prostate Cancer. Journal of Clinical Oncology, 25, 77–84. https://doi.org/10.1200/jco.2005.05.0419

Chicago

Kathleen O’Toole, Bozena K. Malyszko, Mahesh M. Mansukhani, Rachel Brody, Jonas J. Heymann, Mitchell C. Benson, Darleen Vecchio, Ronald D. Ennis, and Peter B. Schiff. 2007. “Phase II Study of Neoadjuvant Androgen Deprivation Followed by External-Beam Radiotherapy With 9 Months of Androgen Deprivation for Intermediate- to High-Risk Localized Prostate Cancer.” Journal of Clinical Oncology 25 (January): 77–84. doi:10.1200/jco.2005.05.0419.